BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6085339)

  • 1. [Tissue polypeptide antigen in breast cancer].
    Nomizu T; Watanabe I; Endo S
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2287-95. PubMed ID: 6085339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tissue polypeptide antigen in thyroid cancer].
    Nomizu T; Watanabe I; Endo S
    Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1289-95. PubMed ID: 6595323
    [No Abstract]   [Full Text] [Related]  

  • 3. [Human breast cancer markers].
    Remennik LV
    Eksp Onkol; 1985; 7(4):3-8. PubMed ID: 2994992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
    Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
    Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological significance of tumor marker].
    Ochi Y
    Rinsho Byori; 1985 Aug; 33(8):831-8. PubMed ID: 3908745
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of serum markers and clinical signs for the diagnosis of cancer of the pancreas].
    Angonese C; Basso D; Del Favero G; Fabris C; Piccoli A; Infantino A; Naccarato R
    Ann Med Interne (Paris); 1988; 139(2):127-8. PubMed ID: 3164986
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 8. CA 125 and TPA as markers in ovarian carcinoma.
    Rodenburg CJ; De Maaker GA; Trimbos JB; Moolenaar AJ; Van Oosterom AT
    Neth J Med; 1985; 28(12):536-40. PubMed ID: 2418375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quality control of the RIA method for 3 tumor markers].
    Fusco A; Ciarniello P; Latella G; Milani C; Antonucci M; Scuderi A; Giannoni MF; Caprilli R
    Minerva Med; 1987 Apr; 78(7):463-4. PubMed ID: 3472102
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines].
    Kausitz J
    Bratisl Lek Listy; 1988 Aug; 89(8):563-76. PubMed ID: 3179762
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of a new tumor marker (CA 50) in epithelial neoplasms. Preliminary study].
    Tozzoli R; Risaliti A; Masiero M; Bruno G
    Minerva Chir; 1987 Nov; 42(21):1785-8. PubMed ID: 3480454
    [No Abstract]   [Full Text] [Related]  

  • 17. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary results of the clinical use of TPA (tissue polypeptide antigen)].
    Dalla Pria AF; Guolo P; Piaserico PL; Ricci G; Berlanda G; Gobbi V; Minello S
    Arch De Vecchi Anat Patol; 1983 Jul; 65(2-3):301-13. PubMed ID: 6680294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor markers in the diagnosis of pancreatic carcinoma].
    Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
    Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.